{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:48:26Z","timestamp":1788306506366,"version":"build-2803163510"},"reference-count":10,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,1]]},"abstract":"<jats:p>The Advisory Committee on Immunization Practices (ACIP), a group of medical and public health experts that provides advice to the Centers for Disease Control and Prevention, normally meets 3 times per year to develop US vaccine recommendations. The ACIP met June 21\u201323, 2023, to discuss respiratory syncytial virus (RSV) vaccines, influenza vaccines, pneumococcal vaccines, meningococcal vaccines, and COVID-19 vaccines. The ACIP also held a special meeting on August 3, 2023, to discuss RSV prophylaxis in infants. This update summarizes the proceedings of these meetings that are most relevant to the pediatric population. Major updates for pediatric clinicians include a new recommendation for the monoclonal antibody nirsevimab for prevention of RSV disease in all infants, recommendations regarding use of 20-valent pneumococcal conjugate vaccine, and discussion of potential forthcoming changes to meningococcal and COVID-19 vaccination recommendations.<\/jats:p>","DOI":"10.1542\/peds.2023-063955","type":"journal-article","created":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T04:05:32Z","timestamp":1693281932000},"source":"Crossref","is-referenced-by-count":21,"title":["Summer 2023 ACIP Update: RSV Prevention and Updated Recommendations on Other Vaccines"],"prefix":"10.1542","volume":"152","author":[{"given":"Sean T.","family":"O\u2019Leary","sequence":"first","affiliation":[{"name":"aDepartment of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra B.","family":"Yonts","sequence":"additional","affiliation":[{"name":"bDepartment of Pediatrics, Children\u2019s National Hospital, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Gaviria-Agudelo","sequence":"additional","affiliation":[{"name":"cDepartment of Pediatrics, University of South Florida Morsani College of Medicine, Tampa, Florida"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Kimberlin","sequence":"additional","affiliation":[{"name":"dDepartment of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant C.","family":"Paulsen","sequence":"additional","affiliation":[{"name":"eDepartment of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio"},{"name":"fDivision of Pediatric Infectious Diseases, Cincinnati Children\u2019s Hospital Medical Center, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2023,10,25]]},"reference":[{"issue":"45","key":"2023110103025634300_B1","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.15585\/mmwr.mm6745a4","article-title":"Updated framework for development of evidence-based recommendations by the Advisory Committee on Immunization Practices","volume":"67","author":"Lee","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"2023110103025634300_B2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1056\/NEJMoa2110275","article-title":"Nirsevimab for prevention of RSV in healthy late-preterm and term infants","volume":"386","author":"Hammitt","year":"2022","journal-title":"N Engl J Med"},{"issue":"2","key":"2023110103025634300_B3","doi-asserted-by":"crossref","first-page":"e2022060435","DOI":"10.1542\/peds.2022-060435","article-title":"RSV among American Indian and Alaska Native children: 2019 to 2020","volume":"152","author":"Atwell","year":"2023","journal-title":"Pediatrics"},{"issue":"1","key":"2023110103025634300_B4","doi-asserted-by":"crossref","first-page":"e2023061803","DOI":"10.1542\/peds.2023-061803","article-title":"Palivizumab prophylaxis in infants and young children at increased risk of hospitalization for respiratory syncytial virus infection","volume":"152","author":"Caserta","year":"2023","journal-title":"Pediatrics"},{"issue":"16","key":"2023110103025634300_B5","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2216480","article-title":"Bivalent prefusion F vaccine in pregnancy to prevent RSV I illness in infants","volume":"388","author":"Kampmann","year":"2023","journal-title":"N Engl J Med"},{"issue":"1","key":"2023110103025634300_B6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.anai.2017.10.020","article-title":"Administration of influenza vaccines to egg allergic recipients: a practice parameter update 2017","volume":"120","author":"Greenhawt","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"20","key":"2023110103025634300_B7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.15585\/mmwr.mm7220a3","article-title":"Estimated effectiveness of JYNNEOS vaccine in preventing mpox: a multijurisdictional case-control study - United States, August 19, 2022-March 31, 2023","volume":"72","author":"Dalton","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"26","key":"2023110103025634300_B8","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1056\/NEJMoa2215201","article-title":"Vaccine effectiveness of JYNNEOS against mpox disease in the United States","volume":"388","author":"Deputy","year":"2023","journal-title":"N Engl J Med"},{"issue":"20","key":"2023110103025634300_B9","doi-asserted-by":"crossref","first-page":"559","DOI":"10.15585\/mmwr.mm7220a4","article-title":"Effectiveness of JYNNEOS vaccine against diagnosed mpox infection - New York, 2022","volume":"72","author":"Rosenberg","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"2023110103025634300_B10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.acap.2022.08.006","article-title":"Association between aluminum exposure from vaccines before age 24 months and persistent asthma at age 24 to 59 months","volume":"23","author":"Daley","year":"2023","journal-title":"Acad Pediatr"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2023-063955\/1548737\/peds.2023-063955.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2023-063955\/1548737\/peds.2023-063955.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T03:04:19Z","timestamp":1698807859000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/152\/5\/e2023063955\/193764\/Summer-2023-ACIP-Update-RSV-Prevention-and-Updated"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,25]]},"references-count":10,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,10,25]]},"published-print":{"date-parts":[[2023,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2023-063955","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,25]]},"article-number":"e2023063955"}}